However, using serum levels of α-synuclein as a biomarker is still unconvincing [13] and, as described in the introduction, conflicting results have been reported for the difference in overall serum levels of auto-antibodies against α-synuclein between PD patients and healthy controls. Here, SNCA is linked to Parkinson disease.